Brighter light during brain tumor surgery may improve outcomes
NCT ID NCT04391062
First seen Jan 10, 2026 · Last updated Apr 28, 2026 · Updated 15 times
Summary
This study tested whether using a higher light dose during a special light-based treatment (photodynamic therapy) could be safe for people with glioblastoma, an aggressive brain cancer. Fourteen patients received the treatment along with standard surgery and chemoradiation. The goal was to find the highest safe light dose and see if it helps delay tumor regrowth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Roger Salengro, CHU Lille
Lille, 59037, France
-
Hôpital Erasme, Clinique Universitaire de Bruxelles
Brussels, Belgium
Conditions
Explore the condition pages connected to this study.